MLH1 and cervical cancer: Sood et al. (2018) have also tested the potential of ESR1, MYOD1, and MLH1. ESR1 transcript levels increase in the tissue, but decrease for MYOD1 and MLH1. However, it is unclear whether epigenetic modifications of these genes influence the development of cervical cancer after chemoradiation therapy.